| HOME >> BIOLOGY >> TECHNOLOGY |
June 30, March 31,
2006 2007 June 30, 2007
RMB RMB RMB US$
(in thousands except for per ADS information)
GAAP net income 45,918 83,725 51,691 6,791
Adjustments:
Stock compensation
expense 321 311 1,379 181
Amortization of acquired
intangible assets 3,729 7,747 15,607 2,050
Non-GAAP adjusted net
income 49,968 91,783 68,677 9,022
GAAP earnings per ADS
- basic 1.68 3.20 1.97 0.26
- diluted (1) 1.68 3.11 1.96 0.26
Non-GAAP adjusted earnings
per ADS 1.83 3.50 2.62 0.34
- basic
- diluted (1) 1.83 3.37 2.61 0.34
Weighted average number
Of ADS
- basic 27,360,000 26,196,308 26,196,308 26,196,308
- diluted (1) 27,385,701 30,882,901 26,317,214 26,317,214
Note:
(1) In computing diluted GAAP and non-GAAP EPS for the three months ended
March 31, 2007, interest expense and amortization in connection with
convertible notes were added back to net income before dividing by the
diluted number of ADS because potential shares from the conversion of
convertible notes were included. For the three months ended June 30,
2007, the total number of potential shares to be converted pursuant to
the conversion of convertible notes was not included in the
computation of diluted EPS because to do so would have been anti-
| SOURCE China Medical Technologies, Inc. Copyright©2007 PR Newswire. All rights reserved |